Pseudohypoaldosteronism type 1: clinical features and management in infancy. - Wikidata - awgldk - TriplyDB

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

http://www.wikidata.org/entity/Q37580096

about

Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene.Severe hyperkalemia is rescued by low-potassium diet in renal βENaC-deficient mice.Pseudohypoaldosteronism Type 1 (arPHA1) Treated With Sodium Polystyrene Sulfonate Pretreated Milk.Phenotypic variation of autosomal recessive pseudohypoaldosteronism type I: a case in point Pseudohypoaldosteronism in a newborn male with functional polymorphisms in the mineralocorticoid receptor genes.

P2860

Q36488880-66D0E4CB-15EA-42D3-9DE9-397594A35A04 Q38752148-5AA48299-0E25-4E04-8012-AAB18C5E03EF Q38875067-A96D5BAE-A327-4680-A18C-E0B0D5A1B2F3 Q41810360-D1BB1080-FCF9-405E-BE1B-5F97234574B8 Q41822493-D5A07342-D589-4F7C-ABD0-A115BC5896CD

P2860

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

http://www.wikidata.org/entity/Q37580096

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

@en

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

@nl

type

label

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

@en

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

@nl

prefLabel

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

@en

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

@nl

P1433

Q37580096-770C13E2-814E-43F6-985A-80253786C9B6

P1476

Q37580096-33DDC4FD-E807-4E2F-88E4-6D09425C637E

P2093

Q37580096-0D314012-2A19-4171-B449-37770ED9E054

Q37580096-72BDA701-BAE0-42A9-A9DF-249EC5B2678C

Q37580096-892218DD-30C0-42E9-8BDF-EA84E096E417

Q37580096-997AE009-DF6D-4618-AE44-CD05841B0F1F

Q37580096-B338459E-86CD-40A2-BF75-6928A07D92B3

Q37580096-B64778AC-DBEF-4D23-B287-0F8F5E6BF1B2

Q37580096-CD50B472-C7C2-485B-9543-2848A018B73D

Q37580096-CDA77C18-8F08-4B77-9771-693E76D46FC9

Q37580096-DD1BB5F1-C5BF-43CF-AEC1-17F1350D6B2D

Q37580096-E15630A4-D21C-490E-B708-F6EDD96B9CBA

P2860

Q37580096-0AB99A7B-3E1C-4B8C-BA35-A5D31C674EC4

Q37580096-0F65710B-8BC7-4E91-9801-FCE04B952E8D

Q37580096-28736C72-1ABD-4711-88E9-049F9560F71D

Q37580096-2B4C7038-41F5-41DB-9BE5-11DFFF350ABD

Q37580096-2EC57DB4-37DD-4599-8D2A-86007793F4B9

Q37580096-3F7CDD6E-DE01-47DE-87EE-246DBB00D226

Q37580096-4741A98A-DC04-4E13-AFFE-D91A06E44EBF

Q37580096-5671320F-D81D-49CD-BB51-0DECC866ACCF

Q37580096-5AC6B65A-50BD-4225-9445-8FB59672427F

Q37580096-5E27AEC9-7018-4AE2-89AE-20472F612931

P304

Q37580096-23EB6AF4-F34A-4256-BDF1-4E4B15E48B6A

P31

Q37580096-FFF5FB76-DB92-44E1-99C0-AA902E346368

Q37580096-a92d723a-b8b4-49d7-857f-22c83957ca81

P356

Q37580096-0B63DA36-CF13-4610-B923-0D75FF4026C9

P478

Q37580096-49FEC638-1662-48D7-95E9-A59F2D0D8ED3

P50

Q37580096-9149C7E7-A969-446A-85C5-CD51A097866C

P577

Q37580096-92F44328-15CF-4148-9717-8AFC5E0A4A3C

P5875

Q37580096-0A68D94E-1B35-428A-B67B-957BB621CE49

P698

Q37580096-0864B41A-5898-4C2C-B8DD-F101AFB92809

P932

Q37580096-8385C84D-F0C4-4A8B-8944-670737D3FF0F

P356

P1433

Endocrinology, diabetes & metabolism case reports

P1476

Pseudohypoaldosteronism type 1: clinical features and management in infancy.

@en

P2093

E Finlay

http://www.w3.org/2001/XMLSchema#string

G Savill

http://www.w3.org/2001/XMLSchema#string

H P Field

http://www.w3.org/2001/XMLSchema#string

J H Barth

http://www.w3.org/2001/XMLSchema#string

N Amin

http://www.w3.org/2001/XMLSchema#string

N P Wright

http://www.w3.org/2001/XMLSchema#string

N S Alvi

http://www.w3.org/2001/XMLSchema#string

S Frazer

http://www.w3.org/2001/XMLSchema#string

T Makaya

http://www.w3.org/2001/XMLSchema#string

T Mushtaq

http://www.w3.org/2001/XMLSchema#string

P2860

A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families

A salt wasting syndrome in infancy

Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1

Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin.

Disturbances of Na/K balance: pseudohypoaldosteronism revisited.

Pseudohypoaldosteronism.

Pseudohypoaldosteronisms, report on a 10-patient series.

The contribution of epithelial sodium channels to alveolar function in health and disease.

Clinical and molecular features of type 1 pseudohypoaldosteronism.

Pseudohypoaldosteronism. Response to long-term treatment with indomethacin.

P304

130010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/EDM-13-0010

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260685020

http://www.w3.org/2001/XMLSchema#string

P698

24616761

http://www.w3.org/2001/XMLSchema#string

P932

3922296

http://www.w3.org/2001/XMLSchema#string